{"id":774580,"date":"2025-11-17T15:55:01","date_gmt":"2025-11-17T15:55:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=774580"},"modified":"2025-11-17T15:55:01","modified_gmt":"2025-11-17T15:55:01","slug":"rheegen-welcomes-renowned-molecular-biologist-dr-zenas-george-to-advisory-team","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/rheegen-welcomes-renowned-molecular-biologist-dr-zenas-george-to-advisory-team_774580.html","title":{"rendered":"RheeGen Welcomes Renowned Molecular Biologist Dr. Zenas George to Advisory Team"},"content":{"rendered":"
RheeGen announces the appointment of Dr. Zenas George, Ph.D., as Science Advisor to support its regenerative biology and bioactive systems research.<\/div>\n

RheeGen® Welcomes Renowned Molecular Biologist Dr. Zenas George to Advisory Team<\/strong><\/p>\n

RheeGen® announces the appointment of Dr. Zenas George, Ph.D., as Science Advisor to support its regenerative biology and bioactive systems research.<\/em><\/p>\n

RheeGen, a biotechnology company, is proud to welcome Dr. Zenas George, Ph.D., as Science Advisor, bringing exceptional expertise in stem cell research, microbiology, and molecular therapeutics to the team.<\/p>\n

RheeGen, founded by Dr. Tommy Rhee, is dedicated to pioneering regenerative solutions through the convergence of cellular engineering, molecular therapeutics, and advanced bioactive systems. With a background in regenerative biology and a passion for translational science, Dr. Rhee established RheeGen® to accelerate the development of next-generation therapeutics that harness the body’s innate healing potential. Under his leadership, the company is focused on unlocking novel regenerative pathways and integrating cutting-edge technologies to address complex biological challenges.<\/p>\n

Dr. George is a molecular biologist specializing in induced pluripotent stem cell (iPSC) technology and regenerative pathway discovery. His scientific guidance will be instrumental in shaping RheeGen’s research strategy, particularly in cellular signaling and the integration of advanced bioactive systems.<\/p>\n

As the newest member of RheeGen’s advisory team, Dr. George brings a distinguished track record in regenerative science and molecular innovation. He previously led R&D programs at Cellular Engineering Technologies, advancing iPSC innovation, and served as Senior R&D Scientist at Jumpcode Genomics, where he developed CRISPR-based tools for next-generation sequencing. He earned his Ph.D. in Biochemistry from the University of Sussex (U.K.) and has contributed to numerous peer-reviewed publications in molecular biology and regenerative science.<\/p>\n

RheeGen® is thrilled to have Dr. George join its growing advisory team and looks forward to the innovation and insight he will bring to its mission. Learn more at<\/strong> www.rheegen.com<\/a>.<\/p>\n

About RheeGen <\/strong><\/p>\n

RheeGen® is a biotechnology company founded by Dr. Tommy Rhee, focused on advancing regenerative science through the integration of cellular engineering, molecular therapeutics, and bioactive system design. Driven by a mission to unlock the body’s innate healing potential, RheeGen® develops innovative platforms that target cellular signaling and regenerative pathways to address complex biological challenges. With a commitment to translational research and next-generation therapeutics, the company is shaping the future of regenerative medicine.<\/p>\n

About Dr. Zenas George, Ph.D. <\/strong><\/p>\n

Dr. Zenas George is a molecular biologist specializing in stem cell research, microbiology, and molecular therapeutics, with a strong focus on induced pluripotent stem cell (iPSC) technology<\/strong> and regenerative pathway discovery. As Science Advisor to RheeGen®, Dr. George provides strategic and scientific guidance on cellular signaling, regenerative biology, and the integration of advanced bioactive systems. He previously led R&D programs at Cellular Engineering Technologies, advancing iPSC innovation, and served as Senior R&D Scientist at Jumpcode Genomics, developing CRISPR-based tools for next-generation sequencing. Dr. George earned his Ph.D. in Biochemistry from the University of Sussex (U.K.) and has contributed to numerous peer-reviewed publications in molecular biology and regenerative science.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> At Large PR<\/a>
Contact Person:<\/strong> Jeff Bearden
Email:<\/strong> Send Email<\/a>
Country:<\/strong> United States
Website:<\/strong> www.atlargepr.com<\/a><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

RheeGen announces the appointment of Dr. Zenas George, Ph.D., as Science Advisor to support its regenerative biology and bioactive systems research. RheeGen® Welcomes Renowned Molecular Biologist Dr. Zenas George to Advisory Team RheeGen® announces the appointment of Dr. Zenas George, … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[438,405,406,445,420],"tags":[],"class_list":["post-774580","post","type-post","status-publish","format-standard","hentry","category-Fitness","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Public-Affairs","category-Science"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/774580","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=774580"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/774580\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=774580"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=774580"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=774580"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}